Moreover, as both FAK and AKT signaling controls prostate tumor angiogenesis by up-regulating vascular endothelial growth factor [22,38], our results showing reduction of VEGF release by 4HPR could be associated with FAK and AKT decreased activity. This evidence concerns the gene AKT1 and prostate neoplasm.